NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Monday 26 April 2010

Lonza remains cautious

Lonza's Q1 demand remained consistent with 2009, but reported that volatility still persists for its custom manufacturing businesses. The company said its pipelines remain strong and it expects higher capacity utilisation this year. Additionally, it is seeing increased levels of partnership discussion in specialty areas such peptides or HAPIs and continuous high level discussions on pipeline outsourcing.
Reuters

No comments: